Modern Healthspan

In this video Dr Harris talks about his recent review paper looking a the omega-3 index and all cause mortality and the omega-3's impact on heart health. Dr. Bill Harris has been a leading researcher in the omega-3 fatty acid field for 40 years. He has over 300 scientific papers on fatty acids and health, the vast majority on omega-3. He has been on the faculty of three medical schools (Univer...

In this episode Dr Harris talks about where to get omega-3 from in your diet. Also supplements, how much and when to take. He also introduces the omega-3 index calculator. Dr. Bill Harris has been a leading researcher in the omega-3 fatty acid field for 40 years. He has over 300 scientific papers on fatty acids and health, the vast majority on omega-3. He has been on the faculty of three medical s...

In this video Dr Harris talks about the omega-3 introduces the omega-3 index and explains what it is. We also talk about its impact on RDW, red blood cell distribution width, which is a component of the PhenoAge calculation Dr. Bill Harris has been a leading researcher in the omega-3 fatty acid field for 40 years. He has over 300 scientific papers on fatty acids and health, the vast majority on om...

In this video Dr Harris introduces the various types of fats and then goes into more detail on essential omega-3 fatty acids. He also discusses omega-6 fatty acids and whether they are positive for health or not. Dr. Bill Harris has been a leading researcher in the omega-3 fatty acid field for 40 years. He has over 300 scientific papers on fatty acids and health, the vast majority on omega-3. He h...

In this video Professor Zemel discusses what he sees as the most promising areas of investigation in healthspan as well as his own health protocol. COSMOS Trial web page https://cosmostrial.org/ Dr Michael Zemel is Professor Emeritus at the University of Tennessee and the founder and chief scientific officer at NuSirt, a company developing solutions to treat chronic diseases of aging and over nutr...

In this video Professor Zemel discusses OS200 the regulated therapy that NuSirt is currently in human trials with for obesity, NAFLD and pre-diabetes. The therapy includes leucine, metformin and sildenafil. Dr Michael Zemel is Professor Emeritus at the University of Tennessee and the founder and chief scientific officer at NuSirt, a company developing solutions to treat chronic diseases of aging a...

In this video Professor Zemel discusses human trials of leucine with B6 and why they tested that combination. These human trials then led to trials in companion dogs, which is a strange twist. And finally he shares his thoughts on the nutraceutical market. Dr Michael Zemel is Professor Emeritus at the University of Tennessee and the founder and chief scientific officer at NuSirt, a company develop...

In this video Professor Zemel introduces his research on leucine and why it is so special. He then talks about how it helps to amplify the effects of resveratrol and NAD precursors. Dr Michael Zemel is Professor Emeritus at the University of Tennessee and the founder and chief scientific officer at NuSirt, a company developing solutions to treat chronic diseases of aging and over nutrition. In his...

In this video Dr Guttuso talks about his experience with lithium and long COVID and the clinical trial that he has started to study this further. He also shares his personal health protocol. Thomas Guttuso, Jr., MD, is a professor of neurology at the University at Buffalo. He has been treating patients with Parkinson’s for over twenty years and has published over thirty articles in leading medical...

In this video Dr Guttuso talks using lithium as a supplement and the different formulations (carbonate, orotate and aspartate), the dosage, safety profile and possible interaction with other medications. Thomas Guttuso, Jr., MD, is a professor of neurology at the University at Buffalo. He has been treating patients with Parkinson’s for over twenty years and has published over thirty articles in le...

In this episode Dr Guttuso talks about two positive random controlled clinical trials of low dose lithium with Alzheimer's and two on going trials. Thomas Guttuso, Jr., MD, is a professor of neurology at the University at Buffalo. He has been treating patients with Parkinson’s for over twenty years and has published over thirty articles in leading medical journals. Dr Guttuso recently publishe...

In this episode Dr Guttuso shares some of his background, how he identified lithium as a potential supplement to slow or prevent Alzheimer's and Parkinson's and the observational data supporting this. Thomas Guttuso, Jr., MD, is a professor of neurology at the University at Buffalo. He has been treating patients with Parkinson’s for over twenty years and has published over thirty articles...

In this episode Professor Sebastiano discusses the future for partial reprogramming and other longevity technologies that he sees as the most promising. Professor Vittorio Sebastiano manages a lab in Stanford University which developed and patented technology for partial cellular reprogramming. He co-founded Turn Bio, where he is now Head of research, to translate this technology into clinical app...

In this video Professor Sebastiano discusses how the timing of the therapy might work, concerns of whether the "point of no return" might be crossed and what aspects of aging are not covered by partial cellular reprogramming. Professor Vittorio Sebastiano manages a lab in Stanford University which developed and patented technology for partial cellular reprogramming. He co-founded Turn Bi...

In this episode Professor Sebastiano discusses the three most advanced interventions that Turn Bio is working on, for skin, immunology and muscles and when they will be available for human trial. Professor Vittorio Sebastiano manages a lab in Stanford University which developed and patented technology for partial cellular reprogramming. He co-founded Turn Bio, where he is now Head of research, to...

In this episode Professor Sebastiano discusses the results that he and his team have had in rejuvenating human cells and how the process could be applied as well as their experience rejuvenating a muscle in an old mouse. Professor Vittorio Sebastiano manages a lab in Stanford University which developed and patented technology for partial cellular reprogramming. He co-founded Turn Bio, where he is...

In this episode Professor Sebastiano discusses the results that he and his team have had in rejuvenating human cells and how the process could be applied as well as their experience rejuvenating a muscle in an old mouse. Professor Vittorio Sebastiano manages a lab in Stanford University which developed and patented technology for partial cellular reprogramming. He co-founded Turn Bio, where he is...

In this video Professor Sebastiano discusses how the mRNA is delivered to the specific cells and how the recent explosion of mRNA interest has changed the development landscape. Professor Vittorio Sebastiano manages a lab in Stanford University which developed and patented technology for partial cellular reprogramming. He co-founded Turn Bio, where he is now Head of research, to translate this tec...

In this episode Professor Sebastiano introduces ERA, Epigenetic Reprogramming of Age technology and talks about his thoughts on some of the causes of aging Professor Vittorio Sebastiano manages a lab in Stanford University which developed and patented technology for partial cellular reprogramming. He co-founded Turn Bio, where he is now Head of research, to translate this technology into clinical...

In this episode Dr Newman talks about ketones as a fuel for the brain and how this becomes more important as we age and the brain can become less able to use glucose. Dr John Newman is a professor at the Buck Institute and at University of California, San Francisco. He hopes to translate what we are learning of the pathways that control aging into therapies to improve the health and independence o...

In this episode Dr Newman talks the ITP lifespan trials that used butanediol but did not see a significant result. He covers what might have caused this and some of the chemistry behind butanediol and butyrate. Dr John Newman is a professor at the Buck Institute and at University of California, San Francisco. He hopes to translate what we are learning of the pathways that control aging into therap...

In this episode Dr Newman talks ways of boosting ketones through ketone supplements, what the different types are and what has been seen with them in human trials. Dr John Newman is a professor at the Buck Institute and at University of California, San Francisco. He hopes to translate what we are learning of the pathways that control aging into therapies to improve the health and independence of o...

In this episode Dr Newman talks about experiments that he and other teams have run on mice lifespan and healthspan while they were on ketogenic diets. Dr John Newman is a professor at the Buck Institute and at University of California, San Francisco. He hopes to translate what we are learning of the pathways that control aging into therapies to improve the health and independence of older adults....

In this episode Dr Newman discusses ketones and their impact on aging. Dr John Newman is a professor at the Buck Institute and at University of California, San Francisco. He hopes to translate what we are learning of the pathways that control aging into therapies to improve the health and independence of older adults. His research at the Buck studies the molecular details of how diet regulate the...

In this episode Dr Davidsohn discusses the next generation therapies that Rejuvenate Bio are working on. We also discuss, klotho, RJB02 and his personal protocol. Dr Noah Davidsohn is a founder and Chief Scientific Officer of Rejuvenate Bio a company developing gene therapies to treat aging and age related diseases. Rejuvenate Bio website https://www.rejuvenatebio.com/ Dr Davidsohn's paper mention...